All body surfaces are exposed to a wide variety of microbes, which significantly influence immune reactivity within the host. This review provides an update on some of the critical novel findings that have been published on the influence of the microbiome on atopic dermatitis, food allergy and asthma. Microbial dysbiosis has consistently been observed in the skin, gut and lungs of patients with atopic dermatitis, food allergy and asthma, respectively, and the role of specific microbes in allergic disorders is being intensively investigated. However, many of these discoveries have yet to be translated into routine clinical practice.
these microbes, their genomic elements and interactions in a given ecological niche. In addition to bacteria, viruses are also considered to be an important component of the microbiome (virome). The composition of the microbiome is dependent on the specific body site examined, resulting in a series of unique habitats within and between individuals that can change substantially over time. 1 This presents significant challenges to the local immune system, which should tolerate the presence of these microbes to avoid damaging host tissue while retaining the ability to respond appropriately to pathogens. The mechanisms that mediate host-microbe communication are highly sophisticated and need to be constantly coordinated. 2 Indeed, disrupted communication between the microbiome and the host due to altered microbiome composition and/or metabolism is thought to negatively influence immune homeostatic networks and may play a role in immune hypersensitivity to environmental exposures, such as allergens. [3] [4] [5] For several years, epidemiological studies have suggested associations between the migration from traditional farming to urban environments, increase in processed food intake, lack of contact with animals and excessive hygiene practices with the increased incidence Abbreviations: AAI, allergic airway inflammation; AD, atopic dermatitis; AHR, airway hyper-responsiveness; AMP, antimicrobial peptides; COPD, chronic obstructive pulmonary disease; CRS, chronic rhinosinusitis; GCS, glucocorticoids; HDM, house dust mite; HMOs, human milk oligosaccharides; ICSs, inhaled corticosteroids; LABAs, long-acting β2 adrenergic receptor agonists;
OIT, oral immunotherapy; PARs, protease-activated receptors; PSMs, phenol-soluble modulins; RSV, respiratory syncytial virus; SCFAs, short-chain fatty acids; TLR, Toll-like receptor.
of asthma, atopic dermatitis and food allergy. However, it is only relatively recently that the importance of the gut, lung and skin microbiomes in regulation of immune tolerance and its aberrations in a variety of human diseases including allergy and asthma has been recognized. 6, 7 In particular, early-life events such as mode of delivery, breastfeeding, mother's diet and health status, antibiotics and other drug usage in pregnancy and early childhood, early-life environment (ie, siblings, pets at home, proximity to farm animals and green areas)
significantly influence the timing of bacterial colonization and establishment, which modify the risk of developing allergies and asthma, as summarized in Figure 1 . [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] In this review, we will highlight some of the recent advances in our knowledge regarding the influence of the microbiome on immune reactivity in the skin, gut and lungs of patients with atopic dermatitis, food allergy and asthma. In addition,
we will discuss the potential translation and challenges associated with microbial-based therapies in patients with these allergic disorders.
| MICROBIOME IN ATOPIC DERMATITIS
The skin microbiome is comprised of bacteria, fungi, viruses and archaeal communities, with bacteria being the most widely studied. 18 The skin microbiome is influenced by age, gender, ethnicity, climate, UV exposure and lifestyle factors. 19 16S ribosomal RNA (rRNA) sequencing has demonstrated that significantly diverse bacterial phyla exist on healthy skin with site-specific differences in composition. This is primarily driven by the physiology of a skin niche. Propionibacterium species are predominantly found in sebaceous sites,
with Corynebacterium and Staphylococcus species occurring in moist microenvironments. Malassezia represents the predominant fungal flora on human skin. 20 Figure 2 illustrates the interactions between the skin microbiome and host cells. Despite Malassezia species having a commensal role in healthy skin, in AD Malassezia may contribute to disease pathogenesis.
Malassezia DNA has been detected in 90% of AD skin lesions, and colonization increases with disease severity. 35 In addition, different
Malassezia strains were found in AD and healthy individuals suggesting the existence of key pathogenic strains in AD. 36 Higher levels of IgE sensitization to Malassezia have been detected in adult AD compared to healthy individuals and childhood AD. 22, 36 Malassezia could contribute to AD pathogenesis by secreting immunogenic proteins that induce proinflammatory cytokines, expression of TLR2 and TLR4 on keratinocytes and induction of auto-reactive T cells.
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Atopic dermatitis is considered a first step in the atopic diathesis, facilitated in part by the defective epidermal barrier of AD. The IL-4/ IL-13 axis in AD is also thought to upregulate the pore-forming claudin-2 expression in the gut leading to barrier defects. 19 In addition to the skin microbiota, AD has been associated with changes in the gut microbiota. Patients with AD have lower levels of Bifidobacterium in the gut compared to healthy controls, and Bifidobacterium levels were inversely correlated with AD disease severity. 37 Several studies have shown that alterations in gut microbiota composition can precede the development of AD. Early gut colonization with C. difficile was associated with AD development, 38 and low gut microbiota diversity and specifically low Bacteroidetes diversity at 1 month were associated with AD development at 2 years of age. 35, 39 A recent whole-metagenome analysis demonstrated a lower abundance of key metabolic pathways in AD children associated with depletion of mucin-degrading bacteria such as Akkermansia muciniphila, Ruminococcus gnavus and Lachnospiraceae. 40 These bacteria not only are able to influence immune development through directly influencing signalling pathways and antigen processing but also can lead to a reduced microbial diversity as these bacteria are able to degrade complex polysaccharides into short-chain fatty acids (SCFAs)-nutrient sources that allow for gut colonization by other microbes. 40 Dog exposure at birth was associated with a doserelated reduced risk of AD in early life, suggesting that exposure to an environment rich in microbial components may be protective. 41 In contrast, antibiotic exposure during the first 2 years of life is associated with an increased risk of AD. 42 Infants with high faecal calprotectin levels (an antimicrobial protein used as a biomarker of
Microbiome of the gut. The gastrointestinal tract is densely colonized by bacteria, and resident microbes directly interact with consumed food, resulting in production of metabolites, such as short-chain fatty acids that promote tolerance responses. Intestinal epithelial cells interact with the microbiome, and the epithelial barrier is heavily influenced by microbiome composition and activities. In the absence of appropriate microbial signals, type 2 immunity is strongly enhanced within the gut mucosa
intestinal inflammation) measured at 2 months of age had an increased risk of AD and asthma by 6 years of age. High faecal calprotectin was also shown to be inversely correlated with levels of E.
coli. Reduced early colonization with E. coli was shown to impair IL-10 regulation. 43 
| MICROBIOME IN FOOD ALLERGY
The human gut microbiome is increasingly being considered as a crucial factor in the development of food allergy, with a strong interrelation between the human gut microbiota, environmental factors, human genetics and gastrointestinal atopy. 4, 44 In particular, the composition and metabolic activity of the gut microbiota are intimately linked with the development of oral tolerance. 45, 46 Therefore, disturbed microbial homeostasis, especially early in life, appears to significantly influence allergic disease susceptibility. Figure 3 illustrates some of the known interactions between the gut microbiome and host mucosal cells.
Recently, the oral bacterial composition in saliva samples from healthy and allergic children up to 7 years of age was described. The result confirmed that early changes in oral microbial composition seem to associate with immune maturation and allergy development. 47 Milk-allergic infants have higher total bacteria and anaerobic bacterial counts compared with healthy control children after 6 months of differential formula intake. In addition, higher proportions of Lactobacilli and lower proportions of Enterobacteria and Bifidobacteria were observed in 46 milk-allergic infants. 48 The spontaneous resolution of milk allergy in infants was associated with a specific gut microbiota composition. 49 Bunyavanich et al showed that Clostridia and Firmicutes were enriched in the infant gut microbiome of subjects whose milk allergy spontaneously resolved. This result suggested that early infant gut microbiota may shape food allergy outcomes in childhood and bacterial taxa within Clostridia and Firmicutes species could be further investigated as probiotic candidates for milk allergy therapy. 49 An additional study examining the gut microbiome of 141 children with egg allergy and healthy controls found that genera from Lachnospiraceae and Ruminococcaceae were associated with egg sensitization; however, there was no association between early-life gut microbiota and egg allergy resolution by age 8 years. 50 A prospective microbiome association study in 14 children with food allergy and 87 children with food sensitization showed that the genera Haemophilus, Dialister, Dorea and Clostridium were underrepresented among subjects with food sensitization, whereas the genera Citrobacter, Oscillospira, Lactococcus and Dorea were underrepresented among subjects with food allergy. 51 An additional prospective study identified both temporal variation and long-term variation in the differential abundance of specific bacterial genera in children developing IgE-associated allergic disease, with Faecalibacterium correlating with IL-10 and Foxp3 mRNA levels. 52 Human milk oligosaccharides (HMOs) have been shown to be important in supporting the establishment of the infant gut microbiome as they are selective substrates for protective microbes such as Bifidobacteria. 53 Two recent studies have described differences in HMO composition that are associated with cow's milk allergy or food sensitization. 54, 55 One potential mechanism for this association is that different HMO profiles may support the establishment of different microbes early in life, thereby indirectly influencing immune maturation and education.
In conclusion, a number of human studies now suggest that food allergy could be associated with changes in microbial exposures in early life, which modifies the development of host immunity and results in pathologic immune responses to food allergens.
| MICROBIOME IN ASTHMA
Composition of the microbiome at all mucosal sites changes dynamically in the first days, months and years of life. If the process of "healthy" and timely colonization is disrupted, the early-life dysbiosis of the gut and lung becomes an important risk factor for atopy, allergy and asthma. In the Canadian Healthy Infant Longitudinal Development (CHILD) study, the lower relative abundance of the bacterial genera Lachnospira, Veillonella, Faecalibacterium and Rothia in the gut was associated with the development of asthma later in life and mechanistically linked with the reduced levels of faecal SCFAs. 56 Another recent study also showed that high levels of SCFAs early in life were protective against later life sensitization and asthma. 57 In a US birth cohort, lower relative abundance of Bifidobacterium, Akkermansia and Faecalibacterium, with higher relative abundance of Candida and Rhodotorula, in the gut of neonates significantly increased the risk of developing multisensitized atopy and asthma later in life. 58 Interestingly, the faecal metabolome of those children at increased risk contained increased levels of pro-inflammatory metabolites, among which 12, 13-DiHOME was able to induce IL-4 production in CD4+ T cells and decreased the abundance of Tregs. 58 
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Importantly, the relative nasopharyngeal abundance of Streptococcus and Staphylococcus negatively correlated with FEV1 and PC20 in children. 64 Children who were breastfed and those who had low rates of respiratory infections in the first 2 years of life were colonized early within the upper respiratory tract with Staphylococcus species, followed by Corynebacterium, Dolosigranulum and Moraxella. [65] [66] [67] However, the most impressive data regarding asthma protection have been observed in relation to traditional farming environments, associated with a high endotoxin and bacterial-containing dust within the home. 85, 86 ) and cellular metabolism might influence microbial colonization and growth within the airways. Figure 4 illustrates the immune responses in the airways that can be influenced by the respiratory microbiome.
In addition to asthma, the potential for microbes to play a role in the initial aetiology of rhinitis, or in exacerbations and progression to more severe inflammatory sequelae (such as asthma) is currently being examined. The phylum Proteobacteria is enriched in children with rhinitis, which may be clinically important given the Proteobacteria-related asthma associations described above. 69 Dysbiosis of the inferior turbinate mucosa microbiota, particularly an increase in S. aureus and a decrease in P. acnes, was associated with high total F I G U R E 4 Microbiome of the airway. Recently, it has been accepted that the airways are not sterile and are inhabited with niche-specific bacteria and fungi. Timely exposure and colonization by commensal microbes attenuate airway allergic inflammation via enhanced expression of programmed death ligand 1 (PDL1) on dendritic cells, and promote regulatory lymphocytes and IgA secretion (left panel). Exposure to pathogenic bacteria can drive excessive host inflammatory responses, enhances Th2/Th17 cell polarization, IgE secretion, disrupts the epithelial barrier and promotes excessive mucus secretion (right panel)
IgE levels in adults with allergic rhinitis. 87 In adults with chronic rhinosinusitis (CRS), the genus Corynebacterium was depleted, accompanied by increased relative abundance of genera from the phyla
Firmicutes (including Staphylococcus and Streptococcus), Proteobacteria
(including Haemophilus, Pseudomonas and Moraxella) or Fusobacteria.
This trend was particularly evident in subjects with comorbidities such as asthma and cystic fibrosis. 88 Similarly, another study reported that middle meatus samples from CRS patients without nasal polyps were enriched in Streptococcus, Haemophilus and Fusobacterium but exhibited loss of diversity compared to healthy, CRS with nasal polyps and allergic rhinitis subject samples. 89 
| LEARNING FROM AN IMAL MOD ELS
Despite the compelling observations and associations in humans that link changes in the microbiota with allergic diseases, very often the causal relationship is not clear. Microbial dysbiosis can be the reason for the disease but can also be the consequence of inappropriate immune reactivity. Animal models have been used to better understand the role of microbes in directly influencing allergic diseases and to elucidate the molecular mechanisms underpinning hostmicrobe crosstalk. dysbiosis. 30 In a mouse itch model, IL-17A and IL-22 drive neutrophils to limit the overgrowth of S. aureus on injured skin. 25 C5aR-deficient mice develop reduced microbial diversity, suggesting that the complement system may also regulate the skin microbiota. 29 A mouse model of AD showed that application of a Vitreoscilla filiformis bacterial lysate reduced the inflammatory manifestations following allergen application. 24 Studies in mice during the neonatal period suggest that tolerance to skin commensals such as S. epidermidis is preferentially established early in life. This supports the hypothesis that exposure to certain microbes at a critical window early in life is required for normal development of the immune system. 30 
| Atopic dermatitis

| Food allergy
The potential role of the gut microbiome in food allergy has been studied in multiple murine models. Rodriguez can induce a wide and complex spectrum of regulatory mechanisms. 121, 122 Increased numbers of histamine-secreting bacteria were observed in adult patients with asthma and correlated with asthma severity. 123 Histamine signalling through the H2R is involved in AAI, 124 while the use of H2R antagonists in children during their first 6 months of life is associated with significantly increased risk of allergic diseases and asthma. 
| Atopic dermatitis
Early intervention aimed at protecting the skin barrier may ameliorate progression of the atopic march in a subset of patients. 19 Skin microbiome manipulation may offer novel therapeutic opportunities, as has been seen with the emollients supplemented with a Vitreoscilla filiformis lysate. 125 Similarly, topically administration of Roseomonas mucosa improved clinical severity scores in adults and children with AD. 125 Autologous microbiome transplant (AMT) of S. hominis and S. epidermidis showed efficacy in controlling S. aureus overgrowth.
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In addition to topical bacterial treatments, oral administration of probiotics has also been examined. Prenatal and post-natal treatment with Lactobacillus and Bifidobacterium strains can reduce risk of AD development in infants, 35, 127, 128 which may associate with changes in T cell-mediated responses. 129 A mixture of probiotic strains was recently shown to reduce SCORAD index and topical steroid use in children with AD. 130 Little has been reported on probiotic treatment of adults with AD, but administration of B. longum 35624 to adults with psoriasis resulted in reduced circulating CRP, TNF and IL-17 levels, possibly due to increased numbers of Tregs, which suggests that bacteria in the gut can influence skin inflammatory activity in adults. 131, 132 Taken together, supplementation with specific probiotic strains may modulate the gut bacteria in a way that influences inflammation within the skin and may protect some children against AD development. 
| Food allergy
The use of probiotics in food allergy treatment and prevention has been examined. Supplementation of cow's milk-allergic children with
Lactobacillus casei and Bifidobacterium lactis did not accelerate cow's milk allergy resolution. 133 However, the combination of L. rhamnosus GG and extensively hydrolysed casein formula did accelerate milk allergy resolution after 6 and 12 months when compared to the formula-only control group. 134 The combination of L. rhamnosus supplementation and peanut oral immunotherapy (OIT) was evaluated in peanut-allergic children for 18 months. The combination was effective in inducing possible sustained unresponsiveness and immune changes that suggested modulation of the peanut-specific immune response. 135 In addition, a sustained beneficial effect on psychosocial impact of food allergy at 3 and 12 months after end of treatment was recently reported. 136 However, the major limitation of this study is that further work is required to determine the relative contributions of the probiotic vs OIT due to the lack of an OIT and L. rhamnosus supplementation control groups in this trial.
| Asthma
A significant number of studies have examined the effect of probiotic supplementation on asthma-related outcomes. A recent systematic review of probiotic studies in children with asthma identified eleven studies eligible with a total of 910 children. The proportion of children with fewer episodes of asthma was significantly higher in the probiotic group than in the control group, but no statistical significance was observed in childhood asthma control test, asthmatic symptom in the day and night, the number of symptom-free days, forced expiratory volume in the first second predicted and peak expiratory flow. 137 In the future, it will be interesting to evaluate microbial administration directly to the airways, in addition to the gut. Table 1 ). Accumulating evidence suggests that microbial exposures might be most effective at preventing atopic disorders during the first 1-2 years of life. However, substantial gaps in our knowledge on the microbiome still exist. In particular, the field has been slow to translate potentially effective microbiome-associated therapies into the clinic via appropriate clinical trials performed to high standards and showing meaningful clinical responses that are superior to current avoidance approaches. While the critical role of the microbiota in cancer immunotherapy has been established, there are currently no published data on the potential role of the microbiota in influencing the success of immunotherapy or biologics in allergy or asthma. 139 In addition, novel probiotics and not just the traditional probiotic strains need to be clinically tested. Furthermore, microbial components or their metabolites should also be examined; in particular, the application of these novel microbial drugs to the diseased site (eg, the airways) must be explored. Lastly, there are no microbial therapeutics currently approved for routine clinical practice, and significant effort and investment are still required to identify the optimal microbial interventions for allergy and asthma.
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